Recent Research Analysts’ Ratings Updates for Intuitive Surgical (ISRG)

Intuitive Surgical (NASDAQ: ISRG) recently received a number of ratings updates from brokerages and research firms:

• 1/15/2026 – Intuitive Surgical had its “neutral” rating reaffirmed by analysts at UBS Group AG.
• 1/9/2026 – Intuitive Surgical had its “outperform” rating reaffirmed by analysts at Sanford C. Bernstein. They now have a $740.00 price target on the stock, up previously from $700.00.
• 1/9/2026 – Intuitive Surgical had its “buy” rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $714.00 price target on the stock.
• 1/7/2026 – Intuitive Surgical had its “buy” rating reaffirmed by analysts at BTIG Research. They now have a $616.00 price target on the stock, up previously from $589.00.
• 1/7/2026 – Intuitive Surgical had its “overweight” rating reaffirmed by analysts at Barclays PLC. They now have a $686.00 price target on the stock, up previously from $635.00.
• 1/5/2026 – Intuitive Surgical was given a new $580.00 price target on by analysts at Evercore ISI.
• 12/29/2025 – Intuitive Surgical had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – Intuitive Surgical had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/18/2025 – Intuitive Surgical had its price target raised by analysts at Truist Financial Corporation from $620.00 to $650.00. They now have a “buy” rating on the stock.
• 12/17/2025 – Intuitive Surgical had its price target raised by analysts at Royal Bank Of Canada from $625.00 to $650.00. They now have an “outperform” rating on the stock.
• 12/15/2025 – Intuitive Surgical had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/12/2025 – Intuitive Surgical had its price target raised by analysts at Wells Fargo & Company from $600.00 to $654.00. They now have an “overweight” rating on the stock.
• 12/11/2025 – Intuitive Surgical was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating. They now have a $635.00 price target on the stock, down previously from $650.00.
• 12/6/2025 – Intuitive Surgical was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 11/22/2025 – Intuitive Surgical was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.

Insider Activity

In other Intuitive Surgical news, EVP Myriam Curet sold 7,562 shares of the stock in a transaction dated Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total value of $4,147,227.66. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at approximately $193,595.79. This represents a 95.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the transaction, the executive vice president directly owned 3,056 shares in the company, valued at $1,772,480. This trade represents a 81.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 114,007 shares of company stock worth $63,533,844. Insiders own 0.70% of the company’s stock.

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.